Format

Send to

Choose Destination
Eur J Public Health. 2019 Apr 1;29(2):345-350. doi: 10.1093/eurpub/cky200.

The legal framework for European cervical cancer screening programmes.

Author information

1
Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
2
Institute of Health Information and Statistics, Praha 2, Czech Republic.
3
Finnish Cancer Registry, Helsinki, Finland.
4
Unit of Cancer Epidemiology, Belgian Cancer Centre, Sciensano, Brussels, Belgium.
5
MedLawconsult, Den Haag, The Netherlands.
6
The Norwegain cervical cancer screening programme, Cancer Registry of Norway, Oslo, Norway.

Abstract

BACKGROUND:

A comprehensive legal framework needs to be developed to run the health services and to regulate the information systems required to manage and to ensure the quality of cancer screening programmes. The aim of our study was to document and to compare the status of legal basis for cervical screening registration in European countries.

METHODS:

An electronic questionnaire including questions on governance, decision-making structures and legal framework was developed. The primary responses were collected by September 2016.

RESULTS:

We sent the questionnaire to representatives of 35 European countries (28 countries of the EU, with the United Kingdom included as 4 countries; 4 EFTA member countries: Iceland, Liechtenstein, Norway, and Switzerland); responses were collected from 33 countries. The legal framework makes it possible to personally invite individuals in 29 countries (88%). Systematic screening registration in an electronic registry is legally enshrined in 23 countries (70%). Individual linkage of records between screening and cancer registries is allowed in 19 of those countries. Linkage studies involving cancer and screening registries have been conducted in 15 countries.

CONCLUSION:

Although the majority of EU/EFTA countries have implemented population-based screening, only half of them have successfully performed record linkage studies, which are nevertheless a key recommendation for quality assurance of the entire screening process. The European legislation is open to the possibility of using health data for these purposes; however, member states themselves must recognize the public interest to create a legal basis, which would enable all the necessary functions for high-quality cancer screening programmes.

PMID:
30265313
DOI:
10.1093/eurpub/cky200

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center